Adjuvant therapy in pancreatic cancer

Table 1 Survival following surgery and adjuvant chemotherapy for pancreatic cancer

Series	Period	Number		Regimen	Median survival (months)	Actuarial survival (%)
		Total	PDAC			1 year	3 year	5 year
Splinter et al[43]	1977-1984	36	18				28
	1980-1984	16	9	5-FU/DOX/MMC			24
Livingstone et al[44]	N/A	285	285	N/A				9
Bakkevold et al*[45]	1984-1987	30	23	5-FU/DOX/MMC	23	70	70	4
		31	24		11	45	30	8
Baumel et al[46]	1982-1988	43	43	Not specified	12
	1982-1988	527	527		12

5-FU = 5-fluorouracil; DOX = doxorubicin; MMC = mitomycin C; * randomised cont rolled trial, PDAC = pancreatic ductal adenocarcinoma.